Study assesses the antibody response to additional dose of COVID-19 vaccine in transplant recipients

A study has begun to assess the antibody response to an additional dose of a COVID-19 mRNA vaccine in kidney and liver transplant recipients, either alone or with a concurrent reduction in immunosuppressive medication.

Related Keywords

United States ,Thomas Pozefsky ,Anthonys Fauci ,Emily Henderson ,Pfizer ,Johns Hopkins University In Baltimore ,National Institute Of Allergy ,National Institutes Of Health ,National Institute ,Infectious Diseases ,National Institutes ,After Transplant Immunosuppression Reduction ,Johns Hopkins University ,Covid 19 ,Transplant ,Allergy ,Antibodies ,Ntibody ,Fell ,Clinical Trial ,Electron ,Immune Response ,Immunosuppression ,Kidney ,Liver ,Liver Transplant ,Medical Research ,Micrograph ,Research ,Cars ,Ars Cov 2 ,Vaccine ,Virus ,